A biotechnology company, Merakris Therapeutics develops innovative biologic products by utilizing cell-derived signaling molecules.
The future of regenerative medicine isn’t just about the cell; it’s about the regenerative qualities of the cell-secreted proteins. Merakris Therapeutics is pioneering the use of cell-derived proteins and nano vesicles derived from immunologically privileged tissue. We develop these therapies for a variety of applications, providing better healthcare solutions and outcomes for both patients and providers.